Genetic Analysis of Subjects Enrolled in the FSGS - Controlled Trial
Main study | Novel Therapies to Treat Resistant Focal Segmental Glomerulosclerosis: Phase II Clinical Trial |
---|---|
Contact name | Jeffrey Kopp |
Contact phone | 301-594-3403 |
Contact email | jeffreyk@intra.niddk.nih.gov |
PI name | Jeffrey Kopp |